Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human CARD11 Antibodies:
anti-Mouse (Murine) CARD11 Antibodies:
anti-Rat (Rattus) CARD11 Antibodies:
Go to our pre-filtered search.
Human Polyclonal CARD11 Primary Antibody for IHC, ELISA - ABIN1030313
Cheng, Hamilton, Kane: Phosphorylation of Carma1, but not Bcl10, by Akt regulates TCR/CD28-mediated NF-κB induction and cytokine production. in Molecular immunology 2014
Show all 2 Pubmed References
Human Polyclonal CARD11 Primary Antibody for IHC (p), IHC - ABIN249816
Rajasekaran, Kumar, Schuldt, Peterson, Vanhaesebroeck, Dixit, Thakar, Malarkannan: Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells. in Nature immunology 2013
Show all 2 Pubmed References
study results suggest variations in the inflammasome, particularly in NLRP1 (show NLRP1 Antibodies) and CARD11, may be associated with chronic Chagas cardiomyopathy
CARD11, a scaffold protein (show HOMER1 Antibodies) required for B-cell receptor (BCR (show BCR Antibodies))-induced NF-kappaB (show NFKB1 Antibodies) activation, was screened in an additional 173 MCL (show FH Antibodies) samples and mutations were observed in 5.5% of cases.
CARMA1 may be aberrantly upregulated in T-ALL, leading to disease progression and migration of leukemic cells to the CNS
findings indicate that a single hypomorphic mutation in CARD11 can cause potentially correctable cellular defects that lead to atopic dermatitis
NF-kappaB (show NFKB1 Antibodies) and beta-catenin (show CTNNB1 Antibodies) signaling by gain-of-function mutations in CARMA1 augments WNT (show WNT2 Antibodies) stimulation and is required for regulating the expression of distinct NF-kappaB (show NFKB1 Antibodies) target genes to trigger cell-intrinsic and extrinsic processes that promote DLBCL lymphomagenesis
CARD11 mutations are rare in patients with CD5 (show CD5 Antibodies)+ DLBCL.
results define molecular determinants that control the production of Lin(Ub)n-Bcl10 (show BCL10 Antibodies), an important signaling intermediate in TCR and oncogenic CARD11 signaling.
We evaluated the relationship between rs4722404 polymorphism in the CARD11 gene, and the risk and clinical features of psoriasis vulgaris in a southern Chinese Han cohort.We identified no association between the SNP and risk of psoriasis vulgaris.
single amino acid oncogenic CARD11 mutations can perturb or bypass the action of redundant inhibitory REs to achieve the level of hyperactive CARD11 signaling required to support lymphoma growth.
Cooperative Control of Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling by an Unusual Array of Redundant Repressive Elements.
LRRK1 physically interacted and potently synergized with CARMA1 to enhance NF-kappaB (show NFKB1 Antibodies) activation.
synergistic activity of Card11 mutant and Bcl6 (show BCL6 Antibodies) in the development of diffuse large B-cell lymphoma in a mouse model
CARMA1 clustering through SH3-GUK domain interactions is required for its activation of NF-kappaB (show NFKB1 Antibodies) signalling
data suggest that Carma1 and MALT1 play previously unappreciated roles in the activation of mTOR signaling in T cells after engagement of the TCR.
CARMA1 CARD shows the first homo-dimeric structure of CARD formed by a disulfide bond and reveals a possible biologically important homo-dimerization mechanism
Data indicate that caspase recruitment domain-containing protein 11 (CARD11) is involved in the pathogenesis of collagen-induced arthritis (CIA (show NCOA5 Antibodies)) by formation of the CARD11/Bcl10 (show BCL10 Antibodies) complex and enhancement of the Th17 cell response.
Genetic approach demonstrates a critical role for the CARD function of CARMA1 in Treg cell development in vivo.
both CARMA1 CARD and BCL10 CARD easily self-oligomerized under physiological conditions.
Findings show that regulation of CARD11 signaling is a critical switch governing the decision between death and proliferation in antigen-stimulated mature B cells.
TCR/CARMA1/NF-kappaB (show NFKB1 Antibodies) controls completion of Th17 differentiation.
The protein encoded by this gene belongs to the membrane-associated guanylate kinase (MAGUK) family, a class of proteins that functions as molecular scaffolds for the assembly of multiprotein complexes at specialized regions of the plasma membrane. This protein is also a member of the CARD protein family, which is defined by carrying a characteristic caspase-associated recruitment domain (CARD). This protein has a domain structure similar to that of CARD14 protein. The CARD domains of both proteins have been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. When expressed in cells, this protein activated NF-kappaB and induced the phosphorylation of BCL10.
CARD-containing MAGUK protein 1
, bcl10-interacting maguk protein 3
, carma 1
, caspase recruitment domain-containing protein 11
, caspase recruitment domain family, member 11
, caspase recruitment domain-containing protein 11-like